摘要
目的 观察阿魏酸钠对早期糖尿病肾病 ( DN)的作用。方法 将 90例伴有微量白蛋白尿的 2型糖尿病患者随机分为常规治疗组 ( RTG组 )和阿魏酸钠治疗组 ( SFG组 ) ,进行治疗观察。结果 与治疗前比较 ,SFG组 UAER及尿 ET均显著降低 ( P <0 .0 1) ,并且脂质代谢紊乱亦有改善 ;而 RTG组 UAER与尿 ET治疗前后比较 ,差异无显著性 ( P >0 .0 5 )。结论 阿魏酸钠具有降低 DN患者肾脏尿微量白蛋白的排泄和改善脂代谢的作用 ,其机制可能与拮抗 ET与其受体结合有关。
Objective To investigate the effects of sodium ferulate on early diabetic nephropathy. Methods 90 cases of type 2 diabetic patients with microalbuminuria were randomly divided into two group:routine treatment group (RTG) and sodium ferulate group (SFG). Results After 4 week sodium ferulate intervention, results showed that the elevated urinary albumin excretion rate (UAER) and urinary endothelin (ET) were markedly decreased and the disorder of lipid metabolism was sinificantly improved in SFG. These parameters except triglyceride (TG) had no significant change throughout the study in RTG. Conclution This study suggested that sodium ferulate could improve early diabetic nephropathy by antagoniging the combination of ET and its receptors and might have some protective effects as well.At the same time, sodium ferulate had good effects on lipid metabolism.
出处
《临床内科杂志》
CAS
北大核心
2001年第6期436-438,共3页
Journal of Clinical Internal Medicine
基金
国家自然科学基金资助项目 (39570 344)
